Moreover, the WHO 2017 classification of PAs recommends that all patients with PAs must be evaluated for the Ki-67 index, especially when the Ki-67 index is ≥3%, indicating tumor aggression [3]. The gene discussed is MKI67; the disease is gonorrhea.